During the past decade, Clinical Hospital Center Zvezdara conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 14 clinical trials were completed. i.e. 155.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Center Zvezdara" #1 sponsor was "Celgene" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Ferring Pharmaceuticals" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Center Zvezdara" #1 collaborator was "Coordinating Centre for Clinical Trials, Charité" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator, "Echo Core Lab Berlin" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Institute for Cardiovascular Computer-assisted Medicine, Charité" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Center Zvezdara" are "Ulcerative Colitis" (5 trials), "Multiple Sclerosis" (4 trials), "Crohn's Disease" (2 trials), "Psoriasis" (2 trials) and "Relapsing Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Clinical Hospital Center Zvezdara" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Center Zvezdara" are "Drug" (32 trials), "Other" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Mirikizumab" (3 trials), "Ozanimod" (3 trials), "CP-690,550" (2 trials) and "Interferon beta-1a" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Center Zvezdara" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Hospital Center Zvezdara". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Clinical Hospital Center Zvezdara, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Center Zvezdara, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Clinical Hospital Center Zvezdara has several departments that took part in Clinical trials: "Clinical Department of Gastroenterology and Hepatology Clinic for Internal Diseases Clinical Hospital Center Zvezdara Dimitrija Tucovica 161" - 2 trials